Publications by authors named "R K Achar"
Cannabinoid and stilbenoid compounds derived from were screened against eight specific fungal protein targets to identify potential antifungal agents. The proteins investigated included Glycosylphosphatidylinositol (GPI), Enolase, Mannitol-2-dehydrogenase, GMP synthase, Dihydroorotate dehydrogenase (DHODH), Heat shock protein 90 homolog (Hsp90), Chitin Synthase 2 (CaChs2), and Mannitol-1-phosphate 5-dehydrogenase (M1P5DH), all of which play crucial roles in fungal survival and pathogenicity. This research evaluates the binding affinities and interaction profiles of selected cannabinoids and stilbenoids with these eight proteins using molecular docking and molecular dynamics simulations.
View Article and Find Full Text PDFArticle Synopsis
- CBF-AML is classified as a favorable risk leukemia and often treated with intensive chemotherapy (IC) that may include the drug gemtuzumab ozogamicin (GO).
- A study of 200 patients showed that adding GO to IC did not improve overall survival (OS) or event-free survival (EFS) compared to IC alone, with 3-year EFS rates of 50% and 47%, respectively.
- In contrast, patients receiving IC with KIT inhibitors (like dasatinib or midostaurin) had a significantly better 3-year EFS of 85%, highlighting the effectiveness of KIT inhibitors over the addition of GO.
The present study was focused on exploring the efficient inhibitors of closed state (form) of type III effector Xanthomonas outer protein Q (XopQ) (PDB: 4P5F) from the 44 phytochemicals of Picrasma quassioides using cutting-edge computational analysis. Among them, Kumudine B showed excellent binding energy (-11.0 kcal/mol), followed by Picrasamide A, Quassidine I and Quassidine J with the targeted closed state of XopQ protein compared to the reference standard drug (Streptomycin).
View Article and Find Full Text PDFan opportunistic human pathogenic bacterium, exhibits resistance to conventional antibiotics by exploiting its quorum sensing mechanism to regulate virulence factor expression. In light of this, disrupting the quorum sensing mechanism presents a promising avenue for treating infections caused by this pathogen. The study focused on using the cytoplasmic quorum sensing receptor CviR from as a model target to identify novel quorum sensing inhibitors from through computational approaches.
View Article and Find Full Text PDF